JPRN-jRCT2080221215未知3 期
ong-term co-administration study of OPC-262 in patients with type 2 diabetes mellitus
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Patients who are capable of giving informed consent
- •2) Patients who are able to take contraceptive measures to avoid pregnancy of the patient or the patient's partner
排除标准
- •Patients with severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus
研究者
相似试验
未知
3 期
A Phase 3 Study of OPC-262 in patients with type 2 diabetesPatients with type 2 diabetesJPRN-jRCT2080220920Otsuka Pharmaceutical Co., Ltd.100
未知
3 期
A long-term clinical study of OPC-262 in patients with type 2 diabetestype 2 diabetesJPRN-jRCT2080221847Otsuka Pharmaceutical Co., Ltd.175
已完成
3 期
A Phase 3 Study of OPC-262 in Patients With Type 2 DiabetesDiabetes, Type 2NCT01193179Kyowa Kirin Co., Ltd.450
未知
2 期
A long-term administration study of OPC-41061 in patients with autosomal dominant polycystic kidney disease (ADPKD) [Extension of study 156-04-001]Autosomal dominant polycystic kidney disease (ADPKD)JPRN-jRCT2080220665Otsuka Pharmaceutical Co., Ltd.17
未知
3 期
A long-term administration study of OPC-41061 in patients with autosomal dominant polycystic kidney disease (ADPKD) (2) [Extension of study 156-05-002]Autosomal dominant polycystic kidney disease (ADPKD)JPRN-jRCT2080220916Otsuka Pharmaceutical Co., Ltd.15